HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 28 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $18,000 | +28.6% | 56,500 | +175.6% | 0.01% | +250.0% |
Q4 2019 | $14,000 | +16.7% | 20,500 | +10.8% | 0.00% | 0.0% |
Q3 2019 | $12,000 | +500.0% | 18,500 | +1056.2% | 0.00% | +300.0% |
Q2 2019 | $2,000 | -99.5% | 1,600 | -98.0% | 0.00% | -98.9% |
Q3 2018 | $402,000 | – | 79,779 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 535,590 | $2,705,000 | 1.58% |
Millrace Asset Group, Inc. | 200,000 | $1,010,000 | 0.79% |
Private Wealth Partners, LLC | 1,000,000 | $5,050,000 | 0.77% |
PERKINS CAPITAL MANAGEMENT INC | 249,700 | $1,261,000 | 0.76% |
Timpani Capital Management LLC | 206,119 | $1,041,000 | 0.30% |
Diametric Capital, LP | 64,329 | $325,000 | 0.28% |
Granahan Investment Management | 941,170 | $4,753,000 | 0.26% |
Kalos Management, Inc. | 69,900 | $308,000 | 0.16% |
SYMMETRY PEAK MANAGEMENT LLC | 85,000 | $429,000 | 0.15% |
B. Riley Wealth Advisors, Inc. | 250,000 | $1,263,000 | 0.15% |